ESCMID eLibrary
Search results
Icon explanation
Abstract
ePoster
Handout
Image
Journal Article
Presentation
Video
Webcast
-
P0146
Antimicrobial activity of ceftobiprole versus other currently marketed cephalosporins and beta-lactams when tested against contemporary Gram-positive and -negative organisms collected from Europe (2015)
22 April 2017
Session: MRSA and MSSA: epidemiology and resistance
Relevance:100%
-
P1355
Activity of linezolid when tested against contemporary European bacterial clinical isolates (2015)
11 April 2016
Session: New and old antibiotics against Gram-positive cocci in vitro
Relevance:100%
-
P1317
Omadacycline activity tested against European bacterial isolates from a combined 2010-2011global surveillance programme
11 April 2016
Session: Omadacycline in vitro and in vivo
Relevance:100%
-
P1339
Delafloxacin activity tested against bacterial pathogens from 44 medical centres in Europe and IL (2014)
11 April 2016
Session: New agents in clinical development against gram-positive bacteria
Relevance:100%
-
P0146
A pharmacokinetic evaluation of sulfamethoxazole 800 mg once daily in the treatment of tuberculosis
09 April 2016
Session: New treatment options for mycobacterial infections
Relevance:100% -
EV0763
Debio 1452 MIC quality control range with Staphylococcus aureus ATCC 29213 using a multi-laboratory study design
25 April 2015
Session: Methods for antibacterial susceptibility testing
Relevance:100%
-
EV0254
Minocycline activity tested against Acinetobacter baumannii, Burkholderia cepacia species complex, Stenotrophomonas maltophila , and select Enterobacteriaceae isolates from a European surveillance programme (2013)
25 April 2015
Session: Antimicrobials: resistance surveillance
Relevance:100%
-
eP187
Antimicrobial activity of ceftobiprole tested against staphylococci and streptococci from European countries and Israel (2013)
10 May 2014
Session: Antibacterial drug activity and interactions in Gram-positive organisms
Relevance:100%
-
eP188
Ceftobiprole activity tested against bacterial isolates from hospitalised patients with pneumonia in European hospitals and Israel (2013)
10 May 2014
Session: Antibacterial drug activity and interactions in Gram-positive organisms
Relevance:100%
-
eP435
Ceftazidime-avibactam activity tested against select Gram-negative organisms from a global surveillance programme (2011) in relation to the ceftazidime epidemiologic cut-off value
10 May 2014
Session: New and old beta-lactamase inhibitors
Relevance:100%
